Coherus Biosciences Inc
NASDAQ:CHRS 4:00:00 PM EDT
Market Cap (Intraday) | 239.43M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $2.28 |
50-Day MA | $2.40 |
200-Day MA | $3.20 |
Coherus Biosciences Inc Stock, NASDAQ:CHRS
333 Twin Dolphin Drive, Suite 600, Redwood City, California 94065
United States of America
Phone: +1.650.649.3530
Number of Employees: 306
Description
Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.